Scientists test drug combo for weight loss safety
NCT ID NCT07310563
Summary
This early-stage study tested how a common anti-nausea medicine (ondansetron) affects the way the body processes a new weight management drug called AMG 133. It involved 59 adults who were overweight or had obesity. The main goal was to check if taking the two drugs together changes the levels of AMG 133 in the blood and to monitor for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CenExel Collaborative Neuroscience Research, LLC Los Alamitos
Los Alamitos, California, 90720, United States
Conditions
Explore the condition pages connected to this study.